SII seeks emergency use authorisation for ‘Covishield’ in India
The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation […]
Say something
-
-
Flipkart Health+ App Launched
06-04-2022
